It should be mentioned, however, that there are studies suggestive of slightly higher adiponectin concentrations in hyperthyroid subjects, particularly with Graves’ disease[18,19], though in these studies concentrations of adiponectin have not been assessed in the same subjects, before and after treatment. This evidence concerns the gene ADIPOQ and Graves disease.